ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diagnosis of metastatic breast cancer is associated with a very poor prognosis.New therapeutic targets are urgently needed, but their development is hampered by a lack of understanding of the mechanisms leading to tumor metastasis.Exemplifying this is the fact that the approximately 30% of all breast cancers overexpressing the receptor tyrosine kinase ErbB-2 are characterized by high metastatic potential and poor prognosis, but the signaling events downstream of ErbB-2 that drive cancer cell invasion and metastasis remain incompletely understood.Here we show that overexpression of ErbB-2 in human breast cancer cell lines leads to phosphorylation and activation of the semaphorin receptor Plexin-B1.This was required for ErbB-2-dependent activation of the pro-metastatic small GTPases RhoA and RhoC and promoted invasive behavior of human breast cancer cells.In a mouse model of ErbB-2-overexpressing breast cancer, ablation of the gene encoding Plexin-B1 strongly reduced the occurrence of metastases.Moreover, in human patients with ErbB-2-overexpressing breast cancer, low levels of Plexin-B1 expression correlated with good prognosis.Our data suggest that Plexin-B1 represents a new candidate therapeutic target for treating patients with ErbB-2-positive breast cancer. Results Overexpression of ErbB-2 results in activation of Plexin-B1 and Rho GTPases.To test whether overexpression of ErbB-2 is sufficient to phosphorylate and activate Plexin-B1, we overexpressed wild-type or constitutively active ErbB-2 in HEK293 cells.This resulted in tyrosine phosphorylation of Plexin-B1 (Figure 1A) as well as in activation of RhoA (Figure 1B) and RhoC (Figure 1D), but not of RhoB (Figure 1C), independent of a Plexin-B1 ligand.Expression of a Plexin-B1 mutant that lacks the intracellular domain blocked RhoA and RhoC activation, indicating that Plexin-B1 signaling is indeed required for RhoA and RhoC activation downstream of ErbB-2 (Figure 1B and Supplemental Figure 1; supplemental material available online with this article; doi:10.1172/JCI60568DS1).In addition to its ability to mediate Rho signaling, Plexin-B1 has been shown to be a GTPase-activating protein (GAP) for R-Ras (29).Consistent with earlier studies showing that R-RasGAP activity is independent of Plexin-B1 phosphorylation by ErbB-2 (18), overexpression of wild-type or Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ErbB receptors and signaling pathways in cancer
Hynes, N. E., & MacDonald, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.010 · Cited by 956
Semaphorins and their receptors in immune cell interactions
Suzuki, K., Kumanogoh, A., & Kikutani, H. (2008) · Nature Immunology · doi:10.1038/ni1553 · Cited by 400
Semaphorin Regulation of Cellular Morphology
Tran, T. S., Kolodkin, A. L., & Bharadwaj, R. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093554 · Cited by 388
Deng, S., Hirschberg, A., Worzfeld, T., Penachioni, J. Y., Korostylev, A., Swiercz, J. M., Vodrazka, P., Mauti, O., Stoeckli, E. T., Tamagnone, L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5381-06.2007 · Cited by 121 · cited 3×
“Plexin-B1–knockout ( Plxnb1 –/– ) mice were generated as described previously (31).”
Self-citationPlexin-B1 plays a redundant role during mouse development and in tumour angiogenesis
Fazzari, P., Penachioni, J., Gianola, S., Rossi, F., Eickholt, B. J., Maina, F., Alexopoulou, L., Sottile, A., Comoglio, P. M., Flavell, R. A., et al. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-55 · Cited by 85 · cited 1×
“This is in line with previous findings in xenograft cancer models (34) and argues against a major role of Plexin-B1 in cells of the tumor microenvironment.”
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Semaphorins and plexins as therapeutic targets
Worzfeld, T., & Offermanns, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4337 · Cited by 318
Self-citationHota, P. K., & Buck, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1019-0 · Cited by 170
Transmembrane semaphorins: Multimodal signaling cues in development and cancer
Gurrapu, S., & Tamagnone, L. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2016.1197479 · Cited by 53
“signaling can instead mediate an anti-migratory effect when associated with MET receptor.(26,70) In addition,”
Metadata
- Authors
- Worzfeld, T., Swiercz, J. M., Looso, M., Straub, B. K., Sivaraj, K. K., & Offermanns, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-04-02
- Volume
- 122
- Issue
- 4
- Pages
- 1296-1305
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2080489428
- Cited by
- 92
- References
- 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. https://app.cochat.ai/papers/10.1172/jci60568
- The paper
- Worzfeld, T., Swiercz, J. M., Looso, M., Straub, B. K., Sivaraj, K. K., & Offermanns, S. (2012). ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. Journal of Clinical Investigation. https://doi.org/10.1172/jci60568
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.